XBiotech Inc.
For the period ended Dec 31, 2024. Filed Mar 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 18, 2025
XBIT$1.97+3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
| ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
|---|
Index to Financial Statements
| Report of Independent Registered Public Accounting Firm (PCAOB Firm ID: 726) | 43 |
|---|---|
| Consolidated Balance Sheets | 44 |
| Consolidated Statements of Operations | 45 |
| Consolidated Statements of Comprehensive Loss | 46 |
| Consolidated Statements of Shareholders’ Equity | 47 |
| Consolidated Statements of Cash Flows | 48 |
| Notes to Consolidated Financial Statements | 49 |
**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.